Technology | August 25, 2008

Cook Claims Rapid Adoption of its EVOLUTION Device to Remove Faulty Pacemaker Leads


August 26, 2008 - Cook Medical today said 200 medical centers in the U.S. have adopted its EVOLUTION Mechanical Dilator Sheath technology, a new tool designed to remove faulty, ineffective leads in patients with cardiac pacemakers.

Cook’s EVOLUTION has been adopted as an alternative to current laser and other powered techniques as it is less invasive, more intuitive to use and about half the cost of laser-powered sheaths.

In the U.S., more than 20,000 to 25,000 leads are extracted annually. Prior to EVOLUTION, leads were removed either through laser extraction systems, manual dilator sheaths or with a snare under local or general anesthetic. These extraction methods had disadvantages in terms of cost, time and or potential patient adverse events.

The device is intended for use in patients requiring the percutaneous dilation of tissue surrounding cardiac leads, indwelling catheters and foreign objects. Cook said the device helps minimizes the risk of vascular perforations seen with laser-powered sheaths utilizing a forward depth of cut.

The EVOLUTION Shortie was launched at Heart Rhythm 2008. The Shortie employs a shorter length to enhance physician control and a specialized distal tip that enables physicians to negotiate through tough fibrous binding adhesions.

Cook’s EVOLUTION is currently available in the United States, Europe and Canada.

For more information: www.cookmedical.com

Related Content

News | EP Lab

November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical ...

Home November 22, 2021
Home
Videos | EP Lab

Christine Albert, M.D., MPH, professor, chair of the Department of Cardiology and the Lee and Harold Kapelovitz ...

Home November 22, 2021
Home
Feature | EP Lab

November 18, 2021 — The U.S. Food and Drug Administration (FDA) is reminding providers about the risk of major ...

Home November 18, 2021
Home
News | EP Lab

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

Home November 16, 2021
Home
News | EP Lab

November 15, 2021 — Vektor Medical Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Home November 15, 2021
Home
Feature | EP Lab | By Arnaud Rosier, M.D.

With 1.2 to 1.4 million new electrophysiology (EP) devices being prescribed to patients around the world each year ...

Home October 28, 2021
Home
News | EP Lab

October 28, 2021 — CathVision, a medical technology company developing electrophysiology (EP) solutions in EP recording ...

Home October 28, 2021
Home
News | EP Lab

October 6, 2021 – Biosense Webster announced the first cases using a radiofrequency balloon ablation catheter were ...

Home October 06, 2021
Home
News | EP Lab
October 1, 2021 — The European Society of Cardiology (ESC) guidelines on cardiac pacing and cardiac resynchronization ...
Home October 04, 2021
Home
Videos | EP Lab
Khaldoun Tarakji, M.D., MPH, associate section head, cardiac electrophysiology, Heart and Vascular Institute at ...
Home October 04, 2021
Home
Subscribe Now